vasexten
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
Voltage-gated L-type calcium channel blocker
Also displays activity at T-type channels.
Chemistry & pharmacology
Loading structure…
SMILES
COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1- Mol. weight
- 491.54 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2103761 ↗
Also known as
- barnidipine
- barnidipine
- barnidipine
- barnidipine
- barnidipine
- barnidipine
- mepirodipine
- mepirodipine hydrobromide
- mepirodipine hydrochloride
- vasexten